These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Study of 2-(2-quinolinylazo)-5-dimethylaminobenzoic acid as a new chromogenic reagent for the spectrophotometric determination of cobalt. Author: Li Z, Guanyu Y, Wang B, Jiang C, Yin G. Journal: Anal Bioanal Chem; 2002 Dec; 374(7-8):1318-24. PubMed ID: 12474104. Abstract: 2-(2-Quinolinylazo)-5-dimethylaminobenzoic acid (QADMAB) is proposed as a new sensitive and selective chromogenic reagent for spectrophotometric determination of cobalt. The QADMAB reacts with cobalt in the presence of cetyl trimethylammonium bromide (CTMAB) medium to form a violet complex of molar ratio 1:2 (cobalt to QADMAB) in the pH range 3.2-5.2. The molar absorptivity of the complex is 1.28x10(5) L mol(-1) cm(-1) at 625 nm. Beer's law is obeyed in range 0.01-0.32 micro g mL(-1). The relative standard deviation for eleven replicate samples of 0.2 micro g mL(-1) is 0.76%. This method was applied to the determination of cobalt in biological samples, Vitamin B(12), alloys and water with good results.[Abstract] [Full Text] [Related] [New Search]